SLC24A2 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
NXPH1 | Neurexophilin 1 | Predicted secreted proteins
| | | | | Group enriched |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | | | | | | Group enriched |
MRAP | Melanocortin 2 receptor accessory protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
FAM19A3 | Family with sequence similarity 19 (chemokine (C-C motif)-like), member A3 | Predicted secreted proteins
| | | | | Group enriched |
LSP1 | Lymphocyte-specific protein 1; Uncharacterized protein | | | | | | Group enriched |
LRRC38 | Leucine rich repeat containing 38 | Predicted membrane proteins
| | | | | Group enriched |
C1orf111 | Chromosome 1 open reading frame 111 | | | | | | Group enriched |
FAM166B | Family with sequence similarity 166, member B | | | | | | Group enriched |
TUBB4A | Tubulin, beta 4A class IVa | Disease related genes Plasma proteins
| | | | | Group enriched |
FNDC9 | Fibronectin type III domain containing 9 | Predicted membrane proteins
| | | | | Group enriched |
NSG2 | Neuron-specific protein family member 2 | Predicted membrane proteins
| | | | | Group enriched |
ASB4 | Ankyrin repeat and SOCS box containing 4 | | | | | | Group enriched |
CNTNAP5 | Contactin associated protein-like 5 | Predicted membrane proteins
| | | | | Group enriched |
PRLHR | Prolactin releasing hormone receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CALY | Calcyon neuron-specific vesicular protein | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
FSTL5 | Follistatin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SEZ6L | Seizure related 6 homolog (mouse)-like | Predicted membrane proteins
| | | | | Group enriched |
CDH18 | Cadherin 18, type 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
TFAP2B | Transcription factor AP-2 beta (activating enhancer binding protein 2 beta) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Group enriched |
DLK1 | Delta-like 1 homolog (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
INA | Internexin neuronal intermediate filament protein, alpha | | | | | | Group enriched |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
CPLX2 | Complexin 2 | | | | | | Group enriched |
PPP1R17 | Protein phosphatase 1, regulatory subunit 17 | | | | | | Group enriched |
SYT14 | Synaptotagmin XIV | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
UNC5A | Unc-5 homolog A (C. elegans) | Predicted membrane proteins
| | | | | Group enriched |
GCGR | Glucagon receptor | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FAM163B | Family with sequence similarity 163, member B | Predicted membrane proteins
| | | | | Group enriched |
LRRTM3 | Leucine rich repeat transmembrane neuronal 3 | Predicted membrane proteins
| | | | | Group enriched |
PABPC1L2A | Poly(A) binding protein, cytoplasmic 1-like 2A | | | | | | Group enriched |
RTL1 | Retrotransposon-like 1 | Predicted membrane proteins
| | | | | Group enriched |
CHRNB4 | Cholinergic receptor, nicotinic, beta 4 (neuronal) | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
PABPC1L2B | Poly(A) binding protein, cytoplasmic 1-like 2B | | | | | | Group enriched |
SLC6A2 | Solute carrier family 6 (neurotransmitter transporter), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM130 | Transmembrane protein 130 | Predicted membrane proteins
| | | | | Group enriched |
ASIC4 | Acid-sensing (proton-gated) ion channel family member 4 | Predicted membrane proteins
| | | | | Group enriched |
FBLL1 | Fibrillarin-like 1 | | | | | | Group enriched |
NKAIN1 | Na+/K+ transporting ATPase interacting 1 | Predicted membrane proteins
| | | | | Group enriched |
PENK | Proenkephalin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SYT4 | Synaptotagmin IV | | | | | | Group enriched |
WDR63 | WD repeat domain 63 | | | | | | Group enriched |
ZFR2 | Zinc finger RNA binding protein 2 | | | | | | Group enriched |
CACNA1B | Calcium channel, voltage-dependent, N type, alpha 1B subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
CELA1 | Chymotrypsin-like elastase family, member 1 | Enzymes
| | | | | Group enriched |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
FRRS1L | Ferric-chelate reductase 1-like | Predicted membrane proteins
| | | | | Group enriched |
KIAA1024 | KIAA1024 | Predicted membrane proteins
| | | | | Group enriched |
MAB21L2 | Mab-21-like 2 (C. elegans) | | | | | | Group enriched |